Lactose (India) Ltd | 158 Cr. | 112 | 247/84.3 | 22.8 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 5.77 Cr. | 3.02 | 4.33/2.75 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 43.5 Cr. | 58.6 | 94.9/44.5 | 14.7 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 32.9 Cr. | 22.5 | 29.0/12.9 | 33.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 71.8 Cr. | 95.3 | 155/79.0 | 11.6 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 318 Cr. | 14.0 | 29.0/11.4 | 17.0 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 5.41 Cr. | 11.2 | 27.1/9.25 | 108 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 315 Cr. | 668 | 1,024/635 | 16.8 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 99.1 Cr. | 22.6 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 808 Cr. | 275 | 449/145 | 22.9 | 98.6 | 0.46 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.21 Cr. | 24.8 | 36.5/22.8 | 104 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 7.37 Cr. | 2.96 | 12.3/2.11 | 81.9 | 17.9 | 0.00 % | 0.44 % | 0.36 % | 10.0 |
Everest Organics Ltd | 303 Cr. | 312 | 324/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,710 Cr. | 1,312 | 1,584/991 | 63.4 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 123 Cr. | 1.32 | 2.72/1.03 | 26.0 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 41.9 Cr. | 17.4 | 18.1/6.40 | 50.5 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.8 Cr. | 11.7 | 24.6/10.0 | 51.3 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 246 Cr. | 689 | 999/355 | 9.05 | 570 | 0.29 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 30.7 Cr. | 30.7 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 25.4 Cr. | 55.6 | 88.7/36.0 | 51.9 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 7.95 Cr. | 3.18 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.7 Cr. | 131 | 154/55.1 | 49.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 11.9 Cr. | 21.7 | 21.7/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 45.3 Cr. | 60.0 | 124/50.0 | 28.6 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 5.21 Cr. | 17.4 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,222 Cr. | 762 | 969/347 | 56.3 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 101 Cr. | 23.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.5 Cr. | 22.7 | 46.0/20.3 | 144 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 158 Cr. | 275 | 418/245 | 16.2 | 110 | 1.64 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 24.4 Cr. | 41.5 | 62.6/14.8 | 69.8 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 68,649 Cr. | 1,172 | 1,593/994 | 19.3 | 527 | 0.38 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 159 Cr. | 256 | 307/156 | 45.8 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 859 Cr. | 171 | 261/148 | 17.1 | 60.5 | 1.46 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 36.4 Cr. | 27.9 | 62.8/21.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,506 Cr. | 2,322 | 2,644/1,008 | 78.2 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.75 Cr. | 0.87 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 300 Cr. | 39.2 | 77.7/34.1 | 21.1 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 6.06 Cr. | 10.4 | 26.0/9.40 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 75.4 Cr. | 3.20 | 6.25/2.82 | 114 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 65,216 Cr. | 30,690 | 31,900/25,200 | 48.9 | 1,657 | 1.34 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,649 Cr. | 734 | 837/486 | 26.7 | 205 | 0.41 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 159 Cr. | 56.1 | 75.8/31.3 | 27.8 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,463 Cr. | 883 | 1,078/440 | | 57.7 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 22,972 Cr. | 1,414 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 863 Cr. | 263 | 325/131 | 46.5 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 453 Cr. | 339 | 428/270 | 16.2 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,323 Cr. | 614 | 950/501 | 51.1 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,759 Cr. | 1,245 | 1,923/991 | 25.7 | 735 | 0.80 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,10,152 Cr. | 3,255 | 3,591/2,513 | 59.2 | 222 | 0.86 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,237 Cr. | 134 | 317/115 | 26.8 | 44.8 | 0.37 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,651 Cr. | 17.6 | 27.9/11.0 | 43.3 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 29,736 Cr. | 1,168 | 1,360/597 | 107 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,755 Cr. | 126 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,20,244 Cr. | 1,752 | 1,960/1,377 | 35.6 | 288 | 0.77 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 1,888 Cr. | 524 | 886/367 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,837 Cr. | 217 | 398/175 | 28.8 | 70.6 | 0.18 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 434 Cr. | 1,435 | 1,750/626 | 20.6 | 621 | 0.10 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,537 Cr. | 668 | 960/418 | 77.2 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,688 Cr. | 147 | 241/91.8 | 245 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 14,328 Cr. | 6,222 | 7,600/4,146 | 39.5 | 374 | 1.88 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,642 Cr. | 2,202 | 2,977/1,381 | 38.1 | 229 | 0.73 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,662 Cr. | 5,218 | 5,850/4,637 | 35.3 | 368 | 1.53 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 227 Cr. | 64.4 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,050 Cr. | 4,164 | 6,453/3,701 | 31.0 | 820 | 0.84 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 123 Cr. | 100 | 348/81.0 | 7.98 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 3,203 Cr. | 523 | 523/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,936 Cr. | 776 | 1,998/670 | 35.7 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 16,449 Cr. | 12,821 | 18,100/5,540 | 68.6 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 512 Cr. | 22.8 | 56.5/21.0 | 30.1 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,823 Cr. | 828 | 1,639/660 | 7.95 | 399 | 1.15 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,869 Cr. | 52.4 | 101/41.7 | 22.8 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 9,582 Cr. | 211 | 359/130 | 26.1 | 50.3 | 0.28 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 129 Cr. | 81.7 | 145/70.1 | 12.5 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 394 Cr. | 110 | 177/90.2 | 96.2 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 88,446 Cr. | 1,937 | 2,403/1,493 | 30.8 | 343 | 0.41 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,132 Cr. | 565 | 980/498 | 12.7 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 33,868 Cr. | 628 | 646/385 | 136 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 844 Cr. | 813 | 1,070/442 | 23.9 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 167 Cr. | 77.3 | 129/60.3 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 978 Cr. | 203 | 370/155 | 20.6 | 103 | 1.48 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 564 Cr. | 351 | 405/271 | 31.5 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,639 Cr. | 919 | 1,310/617 | 43.9 | 373 | 0.54 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,629 Cr. | 1,646 | 2,030/1,303 | 40.0 | 207 | 0.74 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,475 Cr. | 222 | 328/109 | 40.5 | 29.7 | 0.90 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 35,630 Cr. | 1,404 | 1,758/1,052 | 48.5 | 264 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,959 Cr. | 66.7 | 108/57.5 | 20.1 | 56.5 | 1.50 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 72.5 Cr. | 13.4 | 34.7/12.5 | 1.13 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 528 Cr. | 87.1 | 186/74.0 | 6.38 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,213 Cr. | 240 | 388/190 | | 118 | 0.63 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 5,322 Cr. | 432 | 465/267 | 71.4 | 97.6 | 0.28 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,510 Cr. | 1,775 | 3,379/1,243 | 48.9 | 355 | 0.34 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,446 Cr. | 344 | 504/278 | 42.0 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 11,339 Cr. | 468 | 725/389 | 23.7 | 141 | 0.32 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 37,881 Cr. | 1,342 | 1,831/985 | | 299 | 0.19 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 49,243 Cr. | 2,907 | 3,088/1,846 | 57.6 | 98.7 | 1.10 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,880 Cr. | 1,449 | 2,221/1,200 | 21.3 | 557 | 1.38 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 7,008 Cr. | 430 | 659/359 | 25.5 | 141 | 1.16 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 18,831 Cr. | 1,383 | 1,594/816 | 57.2 | 204 | 0.53 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 97,097 Cr. | 1,164 | 1,421/1,020 | 18.1 | 369 | 0.69 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,297 Cr. | 210 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,22,370 Cr. | 1,515 | 1,702/1,310 | 24.6 | 351 | 0.86 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,952 Cr. | 1,967 | 2,641/1,221 | 29.0 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 412 Cr. | 140 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,316 Cr. | 125 | 186/92.2 | 15.6 | 95.8 | 0.40 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 76.2 Cr. | 46.9 | 92.0/40.4 | 127 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 39,776 Cr. | 331 | 405/260 | 48.3 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,880 Cr. | 1,862 | 2,215/1,048 | 45.8 | 179 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 167 Cr. | 105 | 158/76.3 | 23.0 | 43.2 | 1.14 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 177 Cr. | 74.8 | 113/67.8 | 37.9 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,865 Cr. | 8,746 | 9,168/4,800 | 130 | 272 | 0.27 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,946 Cr. | 673 | 863/548 | 39.4 | 103 | 0.68 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 229 Cr. | 109 | 145/69.9 | 9.10 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 59,224 Cr. | 4,953 | 6,440/4,407 | 27.4 | 961 | 0.81 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,706 Cr. | 850 | 1,304/725 | 28.1 | 249 | 1.29 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 486 Cr. | 852 | 1,754/763 | 12.0 | 724 | 1.35 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 33,659 Cr. | 2,695 | 3,486/2,022 | 37.5 | 294 | 1.34 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,267 Cr. | 292 | 571/258 | 22.9 | 120 | 1.75 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,286 Cr. | 357 | 635/312 | 24.9 | 126 | 0.28 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,773.72 Cr | 1,117.23 | | 43.57 | 182.59 | 0.34% | 16.00% | 16.30% | 6.24 |